Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Horowitz

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
CA: a Cancer Journal for Clinicians|September 1, 1992
Ewing's sarcomaM E Horowitz, M G Tsokos, T F DeLaney
Pediatric Clinics of North America|April 1, 1991
Ewing's sarcoma. Radiotherapy versus surgery for local controlM E Horowitz, J R Neff, L E Kun
Biochemical Pharmacology|June 1, 1985
Studies with 4'-deoxyepivincristine (vinepidine), a semisynthetic vinca alkaloidK Mullin, P J Houghton, J A Houghton, et al.
Cancer|August 15, 1993
Long-term survival after central nervous system relapse in a patient with osteosarcomaL H Wexler, T F DeLaney, S Saris, et al.
Journal of the National Cancer Institute|October 16, 1991
Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcomaM A Smith, R S Ungerleider, M E Horowitz, et al.
Genes, Chromosomes & Cancer|November 1, 1992
Cytogenetic studies in subgroups of rhabdomyosarcomaJ Whang-Peng, T Knutsen, K Theil, et al.
Psychophysiology|January 1, 1981
Lateral differences in the latency between finger tapping and the heart beatR J Davidson, M E Horowitz, G E Schwartz, et al.
American Journal of Clinical Pathology|December 1, 1986
Cancer chemotherapy-induced tubular nephrotoxicity evaluated by immunochemical determination of urinary adenosine deaminase binding proteinM P Goren, R K Wright, M E Horowitz, et al.
Cancer Treatment Reports|February 1, 1987
Ifosfamide-induced subclinical tubular nephrotoxicity despite mesnaM P Goren, R K Wright, M E Horowitz, et al.
Cancer|December 15, 1986
Enhancement of methotrexate nephrotoxicity after cisplatin therapyM P Goren, R K Wright, M E Horowitz, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
CA: a Cancer Journal for Clinicians|September 1, 1992
Ewing's sarcomaM E Horowitz, M G Tsokos, T F DeLaney
Pediatric Clinics of North America|April 1, 1991
Ewing's sarcoma. Radiotherapy versus surgery for local controlM E Horowitz, J R Neff, L E Kun
Biochemical Pharmacology|June 1, 1985
Studies with 4'-deoxyepivincristine (vinepidine), a semisynthetic vinca alkaloidK Mullin, P J Houghton, J A Houghton, et al.
Cancer|August 15, 1993
Long-term survival after central nervous system relapse in a patient with osteosarcomaL H Wexler, T F DeLaney, S Saris, et al.
Journal of the National Cancer Institute|October 16, 1991
Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcomaM A Smith, R S Ungerleider, M E Horowitz, et al.
Genes, Chromosomes & Cancer|November 1, 1992
Cytogenetic studies in subgroups of rhabdomyosarcomaJ Whang-Peng, T Knutsen, K Theil, et al.
Psychophysiology|January 1, 1981
Lateral differences in the latency between finger tapping and the heart beatR J Davidson, M E Horowitz, G E Schwartz, et al.
American Journal of Clinical Pathology|December 1, 1986
Cancer chemotherapy-induced tubular nephrotoxicity evaluated by immunochemical determination of urinary adenosine deaminase binding proteinM P Goren, R K Wright, M E Horowitz, et al.
Cancer Treatment Reports|February 1, 1987
Ifosfamide-induced subclinical tubular nephrotoxicity despite mesnaM P Goren, R K Wright, M E Horowitz, et al.
Cancer|December 15, 1986
Enhancement of methotrexate nephrotoxicity after cisplatin therapyM P Goren, R K Wright, M E Horowitz, et al.
Pageof 8